Real Chemistry Executive and Leadership Team

Jeffrey Lupinacci, the Chief Financial Officer at Real Chemistry, manages the company's financial health and strategic fiscal planning. Directing all financial operations, Lupinacci ensures sound economic management and drives profitability through meticulous budget oversight and resource allocation. This critical role involves financial forecasting, investment analysis, and maintaining strong relationships with financial institutions to support the company's commercial success. By optimizing financial strategies, Jeffrey Lupinacci directly contributes to Real Chemistry's ability to deliver AI-powered healthcare experiences. Lupinacci's leadership ensures financial stability and supports the expansion of services across key markets.

Jj Schmuckler, the Group President and Chief Revenue Officer at Real Chemistry, drives revenue growth and client acquisition across key business segments. Directing sales and business development efforts, Schmuckler ensures alignment with the company's mission to power commercial success in healthcare. This leadership position involves cultivating strategic partnerships and expanding market reach through innovative, idea-driven approaches. By focusing on client value and revenue optimization, Jj Schmuckler directly enhances Real Chemistry's market impact. Schmuckler's expertise in revenue generation is crucial for scaling AI-powered healthcare experiences and solidifying the company's position.

Brenna Terry, the President, Integrated Communications at Real Chemistry, leads the strategic development and execution of comprehensive communication programs. Directing teams across various communication disciplines, Terry ensures cohesive messaging that amplifies Real Chemistry's AI-powered solutions and customer-centric approach. This role involves overseeing public relations, digital engagement, and content strategy to foster strong client relationships and enhance market presence. By integrating diverse communication channels, Brenna Terry directly supports the commercial success of healthcare companies. Terry's leadership ensures that all communications align with the company's mission and drive meaningful engagement.

Kevin Johnson, the Group President and Managing Partner at Real Chemistry, drives strategic growth and operational excellence across multiple business units. Directing key client engagements and partnership development, Johnson ensures the effective delivery of AI-powered healthcare experiences. This leadership role involves fostering innovation, optimizing service delivery, and expanding the company's footprint in the healthcare sector. By focusing on client success and strategic partnerships, Kevin Johnson directly contributes to Real Chemistry's commercial objectives. Johnson's leadership is instrumental in translating the company's vision into tangible results and market leadership.

Brandon Pletsch, the President, Scientific Visualization at Real Chemistry, leads the innovation and application of advanced visualization technologies. Directing the scientific visualization division, Pletsch ensures the creation of compelling, data-driven visual narratives that enhance understanding of complex healthcare information. This role involves leveraging AI to produce impactful visualizations that support client success and drive commercial outcomes. By pushing the boundaries of scientific communication, Brandon Pletsch directly contributes to Real Chemistry's mission of creating idea-driven healthcare experiences. Pletsch's expertise is vital for translating scientific data into accessible and persuasive visual content.

Kath Harrison, the Group President, International Growth at Real Chemistry, spearheads the expansion of the company's services into global markets. Directing international strategy and operations, Harrison identifies opportunities to deliver AI-powered healthcare experiences to a broader client base. This leadership role involves navigating diverse market landscapes and building strategic alliances to drive international revenue. By focusing on global expansion, Kath Harrison directly supports Real Chemistry's mission to power the commercial success of healthcare companies worldwide. Harrison's efforts are crucial for extending the company's reach and impact across key international regions.

Mary Duch, the Group President, Integrated Communications at Real Chemistry, oversees the strategic direction of integrated communication services. Directing cross-functional teams, Duch ensures the seamless execution of communication strategies that align with client objectives and enhance market presence. This role involves managing client relationships and driving the development of innovative communication solutions that leverage AI and customer-centric principles. By fostering collaboration and strategic alignment, Mary Duch directly contributes to Real Chemistry's ability to deliver impactful healthcare experiences. Duch's leadership ensures cohesive messaging and strengthens the company's reputation for excellence.

Andrew Johnson, the Chief Information Officer at Real Chemistry, directs the company's technology strategy and infrastructure. Overseeing all IT operations, Johnson ensures the robust and secure deployment of AI-powered solutions that drive healthcare experiences. This leadership role involves managing data architecture, cybersecurity protocols, and the integration of new technologies to enhance operational efficiency and client service delivery. By optimizing the digital backbone, Andrew Johnson directly supports Real Chemistry's mission to create idea-driven healthcare experiences with the customer at the center. Johnson's focus remains on scalable technology frameworks that empower the organization's growth and maintain a competitive edge in the market.

Ericka McKenna, the Chief Marketing Officer at Real Chemistry, spearheads the company's brand strategy and market positioning. Directing all marketing initiatives, McKenna crafts compelling narratives that highlight Real Chemistry's AI-powered solutions for healthcare companies. This role involves overseeing market research, digital campaigns, and public relations to amplify the company's impact and attract new clients. By driving innovative marketing approaches, Ericka McKenna ensures that the customer-centric philosophy is central to all external communications. McKenna's strategic vision enhances market penetration and reinforces Real Chemistry's leadership in creating transformative healthcare experiences.

Ujwal Pyati, the Chief Medical Officer at Real Chemistry, provides critical medical and scientific expertise to guide the development of healthcare solutions. Directing clinical strategy, Pyati ensures that AI-powered experiences are grounded in scientific rigor and patient-centric principles. This role involves collaborating with cross-functional teams to translate complex medical insights into actionable strategies that drive commercial success for healthcare clients. By championing medical integrity, Ujwal Pyati reinforces Real Chemistry's commitment to delivering impactful and ethical healthcare experiences. Pyati's guidance is essential for maintaining the highest standards of medical accuracy and relevance.